Congress is moving to add xylazine, also known as “tranq,” to a list of controlled substances. The drug is approved for use in animals, but dealers have been adding it to the fentanyl supply.
A bipartisan group of U.S. senators and representatives plans to introduce legislation to designate a veterinary tranquilizeras a controlled substance, aiming to help law-enforcement authorities crack down on illegal use.
Xylazine, known to some users as “tranq,” is approved only for use in animals such as horses and cattle. But dealers have been adding it toContinue reading your article with
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
WSJ News Exclusive | Uber Eats to Take Down Thousands of Virtual Brands to Declutter the AppUber Eats is taking thousands of online-only brands off its app out of concern that the platform is getting clogged by restaurants listing multiple delivery options with different names but the same menu
続きを読む »
WSJ News Exclusive | Russia Supplies Iran With Cyber Weapons as Military Cooperation GrowsTehran is receiving advanced surveillance software after providing drones for Ukraine battlefield, people familiar with the matter said, adding another layer to a burgeoning alliance that the U.S. sees as a threat.
続きを読む »
WSJ News Exclusive | Drug Middlemen Accused of Price Fixing by Ohio Attorney GeneralThe state’s lawsuit alleges certain pharmacy-benefit managers shared drug pricing and other information to gain leverage during rebate negotiations with pharmaceutical companies
続きを読む »
WSJ News Exclusive | Lyft Hires New CEO as Founders Step Back Amid Struggles With CompetitionDavid Risher, board member since 2021, will succeed co-founder Logan Green, as Lyft faces tough competition from Uber and a battered stock price.
続きを読む »